Bedside to bench: The risk of bleeding with parenteral omega-3 lipid emulsion therapy.
暂无分享,去创建一个
[1] J. Folkman,et al. Reversal of Parenteral Nutrition–Associated Liver Disease in Two Infants With Short Bowel Syndrome Using Parenteral Fish Oil: Implications for Future Management , 2006, Pediatrics.
[2] T. To,et al. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. , 2004, Journal of pediatric surgery.
[3] W. Seeger,et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. , 2002, American journal of physiology. Heart and circulatory physiology.
[4] M. Ragaller,et al. Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery , 2002, British Journal of Nutrition.
[5] W. Seeger,et al. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. , 1996, Biochemical pharmacology.
[6] J. Schmee,et al. Fish Oil, Atherogenesis, and Thrombogenesis a , 1994, Annals of the New York Academy of Sciences.
[7] R. Ball,et al. Development and validation of a total parenteral nutrition model in the neonatal piglet. , 1993, The Journal of nutrition.
[8] D. Churchill,et al. Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. , 1992, Journal of the American Society of Nephrology : JASN.
[9] N. Hamasaki,et al. Beneficial effect of EPA (20:5 n-3 PUFA) on preventing venous thromboembolism: a rat tail thrombosis model experiment. , 2013, Thrombosis research.
[10] M. Seeberger,et al. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. , 2012, Transfusion medicine reviews.